Review of flavopiridol, a cyclin-dependent kinase inhibitor, as breast cancer therapy

2002 ◽  
Vol 29 (3) ◽  
pp. 77-85
Author(s):  
A TAN ◽  
S SWAIN
Keyword(s):  
Breast Cancer ◽  
Cancer Therapy ◽  
Kinase Inhibitor ◽  
Cyclin Dependent Kinase ◽  
Breast Cancer Therapy ◽  
Cyclin Dependent Kinase Inhibitor

scholarly journals Estrogen-mediated epigenetic repression of the imprinted gene cyclin-dependent kinase inhibitor 1C in breast cancer cells

2011 ◽  
Vol 32 (6) ◽  
pp. 812-821 ◽  
Author(s):  
Benjamin A.T. Rodriguez ◽  
Yu-I Weng ◽  
Ta-Ming Liu ◽  
Tao Zuo ◽  
Pei-Yin Hsu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Cells ◽  
Breast Cancer Cells ◽  
Kinase Inhibitor ◽  
Cyclin Dependent Kinase ◽  
Imprinted Gene ◽  
Cyclin Dependent Kinase Inhibitor ◽  
Epigenetic Repression

scholarly journals Silencing cyclin-dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines

2016 ◽  
Vol 14 (2) ◽  
pp. 1523-1530 ◽  
Author(s):  
Miao Deng ◽  
Jianguang Wang ◽  
Yanbin Chen ◽  
Like Zhang ◽  
Gangqiang Xie ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cell Lines ◽  
Cancer Cell ◽  
Breast Cancer Cell ◽  
Kinase Inhibitor ◽  
Cancer Cell Lines ◽  
Breast Cancer Cell Lines ◽  
Cyclin Dependent Kinase ◽  
Cyclin Dependent Kinase Inhibitor

scholarly journals Association of a genetic variant in cyclin-dependent kinase inhibitor 2A gene with the increased risk of breast cancer

2018 ◽  
Vol 29 ◽  
pp. viii3
Author(s):  
S. Shahid Sales ◽  
M. Mehramiz ◽  
S.A. Aledavood ◽  
M. Joudi Mashhad ◽  
S. Ahmadi Simab ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Genetic Variant ◽  
Kinase Inhibitor ◽  
Cyclin Dependent Kinase ◽  
Cyclin Dependent Kinase Inhibitor ◽  
Increased Risk
Sign in / Sign up

Export Citation Format

Share Document